Now there is a treatment for your double chin! The FDA has approved KYBELLATM (deoxycholic acid) injection, which contours and improves the appearance of moderate to severe submental fullness due to submental fat. Submental fullness, also known as “double chin,” can affect adult women and men of all ages and weights, and is influenced by multiple factors, including aging and genetics. Submental fullness is often resistant to diet and exercise.
WHAT IS KYBELLA™?
Clinically Proven, KYBELLA™, (deoxycholic acid) injection, also known as ATX-101, is the first and only FDA-approved injectable drug that contours and improves the appearance of submental fullness due to submental fat.
KYBELLA is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. The safe and effective use of KYBELLA™ for the treatment of subcutaneous fat outside the submental region has not been established and is not recommended.